Search

Displaying results 5791 - 5800 of 7452 in total
  1. Drug

    Clocapramine

    go.drugbank.com/drugs/DB09003
    Experimental

    Clocapramine is an atypical antipsychotic of the imidobenzyl class which was introduced in Japan in 1974 for the treatment of schizophrenia.

  2. Drug

    Pidotimod

    go.drugbank.com/drugs/DB11364
    Investigational

    Pidotimod is a synthetic dipeptide with immunomodulatory properties.

  3. Drug

    Elvucitabine

    go.drugbank.com/drugs/DB06236
    Investigational

  4. Drug

    Lys-plasminogen

    go.drugbank.com/drugs/DB32870
    Experimental

    Lys-plasminogen is a truncated form of natural human plasminogen.

  5. Drug

    QS-21

    go.drugbank.com/drugs/DB05400
    Investigational

    QS-21 is an investigational adjuvant, which is a substance added to vaccines and other immunotherapies that is designed to enhance the body’s immune response to the antigen contained within the treatment. It is the leading member of the ...

  6. Drug

    Cadexomer iodine

    go.drugbank.com/drugs/DB16572
    Investigational

    Categories: Preparations for Treatment of Wounds and Ulcers
  7. Drug

    Meladrazine

    go.drugbank.com/drugs/DB13272
    Experimental

    Categories: Drugs for Urinary Frequency and Incontinence
  8. Drug

    Quifenadine

    go.drugbank.com/drugs/DB13713
    Experimental

    Categories: Antihistamines for Systemic Use
  9. Drug

    Anti-SARS-CoV-2 equine immunoglobulin fragments

    go.drugbank.com/drugs/DB16368
    Investigational

    immunoglobulin fragments, also known as INOSARS, is a polyvalent passive immunization being tested in the clinical trial NCT04514302 (Safety and Efficacy of Anti-SARS-CoV-2 Equine Antibody Fragments (INOSARS) for

  10. Drug

    GS030-DP

    go.drugbank.com/drugs/DB17847
    Investigational

    GS030-DP is an optogenetic gene therapy being investigated for the treatment of retinitis pigmentosa.